Forex
BioVie’s Bezisterim Shows Mixed Phase 2 Long COVID Results
Phase 2 trial of the drug failed to meet primary endpoints but highlighted potential benefits in high-burden subgroups, paving the way for Phase 3 testing.
Asian currencies rise as yen steadies near seven‑month high, dollar slips
The yen rallied 4% in September, touching 152.89 per dollar, while the U.S. dollar index edged up to 98.83 and the euro rose to $1.1629.
Iran strikes U.S. Jordan base, ships amid six-month escalation
Missile attacks and oil tanker strikes by Iran and Iranian-backed Houthis disrupt regional security and raise oil prices to $100 a barrel.
US Futures Slip; SMI Tumbles 1.3% on Oil, Rates, Bank Woes
The SMI fell 1.3%, with UBS leading declines as Powell's 5.041% yield and Brent crude near $108 weigh on stocks.
Surf Air Mobility attends FAA’s eVTOL integration program launch
Surf Air Mobility participated in the Federal Aviation Administration’s Project Nexus launch, marking a milestone in electric vertical takeoff and landing aircraft deployment ahead of a 2026 Hawaii demonstration program.
Pound Falls on Disappointing UK Jobs Data as Dollar Gains Strength
Sterling dropped after UK private-sector payrolls fell 34,000 in August, while the dollar index approached 100 ahead of Wednesday's Federal Reserve decision.
Pound Falls as UK Jobs Data Disappoints; Dollar Steady
The pound weakened against the dollar after UK employment figures came in below expectations.
China Tightens Outbound Travel Controls Over Technology Security
Beijing enforces new travel-restriction rules targeting citizens who violate export controls or harm national interests abroad, with bans lasting six months to three years.
Asian Currencies Slip as Yen Retreats Ahead of Fed, BOJ Decisions
Asian currencies weakened as the Japanese yen pulled back from a seven-month high, with markets bracing for U.S. and Japanese monetary policy moves on Wednesday and Friday.
Asian Currencies Slip as Yen Pulls Back Ahead of Fed, BOJ Decisions
Asian currencies declined while the yen retreated, with markets awaiting upcoming policy decisions from the Federal Reserve and the Bank of Japan.
Roche Partner MediLink Reports 54% OS Risk Reduction for Tam-Peli in Phase III SCLC Trial
MediLink's interim TAISHAN-302 data showed tambotatug pelitecan reduced death risk 54% versus topotecan in relapsed small-cell lung cancer, with 71% progression risk reduction.
Asian Currencies Climb as Yen Holds Near Seven-Month High, Dollar Falters
The yen advanced nearly 4% in September after touching 152.89 against the dollar, while the dollar index hovered near 98.83 as traders priced in a near-certain BoJ rate hike on Sept. 18.
Novartis faces Phase 3 trial clinical setback for its $12B Avidity acquisition drug in myotonic dystrophy type 1
Finance Review Daily is tracking this developing story; finance review daily will provide updates as verified details become available.
Yen Holds Near February High as Oil Near $100 Weighs on the Dollar
The Japanese yen maintained strength near its strongest level since February, buoyed by safe-haven demand and oil-driven inflation concerns, while the dollar slumped ahead of U.S. inflation data and Federal Reserve policy expectations.
Loonie Holds Near 12-Day Low as Oil Support Fails to Offset Dollar Strength
The Canadian dollar traded near C$1.392 against the U.S. dollar Monday, pressured by rising Fed rate-hike odds and a firmer greenback despite Brent crude topping $108.
Canadian Dollar Drops Near 12-Day Low as Oil Support Fails to Offset Dollar Strength
USD/CAD traded around C$1.392 Monday, near its lowest level since early September, as weak inflation data and a stronger U.S. dollar outweighed oil price gains.
Elicio Therapeutics Shifts Focus to Metastatic Cancer with KRAS Immunotherapy
The biotech firm pivots its lead candidate, ELI-002, toward treating advanced-stage cancers, citing unmet needs in metastatic pancreatic cancer and broader KRAS-mutant disease.
Aptar Group Teams Up with MGH on Nose-to-Brain Drug Delivery Research
AptarGroup Inc. and Massachusetts General Hospital (MGH) announced a research collaboration to advance nose-to-brain drug delivery, targeting neurological disorders like Alzheimer’s and Parkinson’s.
dLocal Adopts Oscilar’s Compliance Platform for AML and Sanctions Screening
Cross-border payment firm dLocal selects Palo Alto-based risk and compliance platform Oscilar to streamline anti-money laundering operations across 60 global markets.
SpyGlass Pharma’s Glaucoma Lens Shows Strong Clinical Results in Early Trials
The biotech firm highlights a $13B market opportunity with a novel intraocular lens designed to reduce intraocular pressure post-cataract surgery.
Black Wednesday: The Day a Single Trade Made Billions
On September 16, 1992 — a date now permanently known as "Black Wednesday" — the UK government was forced to withdraw the pound sterling from the European Exchange Rate Mechanism after a wave of currency speculation made…
U.S. Accuses Chinese AI Firms of Industrial-Scale Model Extraction
CISA, NSA and FBI warn that Chinese companies have siphoned billions of tokens from U.S. frontier AI models since late 2024 to accelerate their own systems.
Treasury Chief Bessent Backs Using U.S. Financial Power as Foreign Policy Tool
Scott Bessent says the U.S. balance sheet should build allies in the Western hemisphere, citing Argentina and a rare yen intervention — even as Treasury efforts fail to curb long-term borrowing costs.
McGraw Hill Sees AI as Key Growth Driver in Education amid Rising Demand
The company highlights its digital-first approach, expanding AI integration and global market expansion as it capitalizes on education sector growth.